Top Markets
#1 Islamic Coin Islamic Coin +154.27%
#2 PulseChain PulseChain +51.99%
#3 BOOK OF MEME BOOK OF MEME +44.89%
#4 DogBull DogBull +34.92%
#5 Nockchain Nockchain +18.68%
#6 ORDI ORDI +17.36%
#7 Ergo Ergo +17.32%
#8 rsERG rsERG +16.99%
#9 PondCoin PondCoin +16.22%
#10 Merlin's Seal BTC Merlin's Seal BTC +15.88%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
TCR2 Therapeutics Inc. TCR2 Therapeutics Inc.

TCR2 Therapeutics Inc.

TCRR
Classifica tra le azioni #27038
TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on... TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on developing cutting-edge T cell receptor (TCR) therapies for cancer patients. The company's lead investigational treatment, gavo-cel, is a unique mono TCR Fusion Construct T cell (TRuC-T cell) designed to target mesothelin-positive solid tumors. This therapy is currently being evaluated in Phase I/II clinical trials for non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. Furthermore, TCR2 Therapeutics has concluded preclinical development for TC-510, another TRuC-T cell specifically engineered to target mesothelin on solid tumors. They are also advancing TC-520, a CD70-targeting TRuC-T cell designed with fratricide resistance for treating renal cell carcinoma. Founded in 2015, the company, formerly known as TCR2, Inc. until its name change in November 2016, is headquartered in Cambridge, Massachusetts.
Prezzo delle azioni
$1.48
Ultima sincronizzazione: 2023-05-31
Capitalizzazione di mercato
$35.54M
Variazione (1 giorno)
-5.73%
Variazione (1 anno)
0.00%
Paese
US
Scambia TCR2 Therapeutics Inc. (TCRR)

Categoria

Healthcare
Storico del prezzo dell'azione per TCR2 Therapeutics Inc. (TCRR)
Prezzo di chiusura più alto: $1.83 il 2023-05-01

Prezzo di chiusura più basso: $16.51 il 2019-02-01
Storico del prezzo dell'azione di TCR2 Therapeutics Inc. dal 2019 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2023 73.43%
2022 -78.52%
2021 -83.60%
2020 79.84%
2019 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $552.07 39.99%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $168.77 527.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 56.22%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -14.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $758.23 6.53%
CH